Select Page

South Delhi Pharma, New Delhi, India

PIQRAY ® (alpelisib) 50 mg film-coated tablets.

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

PIQRAY is a prescription medicine. PIQRAY is used to treat breast cancer
INDICATIONS AND USAGE
PIQRAY is a kinase inhibitor indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer as detected by an FDA-approved test following progression on or after an endocrine-based regimen.
DOSAGE FORMS & STRENGTHS
Tablets: 50 mg, 150 mg, 200 mg
Manufactured By: Novartis Pharmaceuticals Corporation
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “PIQRAY ® (alpelisib) 50 mg film-coated tablets” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

15 + 4 =

Alpelisib, sold under the brand name Piqray, is a medication sold by Novartis and used to treat certain types of breast cancer. It is used together with fulvestrant.

In the European Union alpelisib is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)‑positive, human epidermal growth factor receptor 2 (HER2)‑negative, locally advanced or metastatic breast cancer with a PIK3CA mutation after disease progression following endocrine therapy as monotherapy.

1 review for PIQRAY ® (alpelisib) 50 mg film-coated tablets.

  1. Social Media Marketing

    I just could not go away your website prior to suggesting that I extremely enjoyed the standard info an individual provide in your guests? Is gonna be again incessantly in order to inspect new posts.

    https://www.blogexpander.com/article-advertising-advice-to-help-you-find-the-key-to-success/

Add a review

Your email address will not be published.